Year-end Sale % OFF 
Abstract
Allergen-specific immunotherapy (ASIT) is currently recognized as the only treatment that can affect all links in the pathological process of allergic diseases. Airway hyperresponsiveness is significantly reduced in case of allergy respiratory manifestations, which reduces symptoms severity and the need for drugs. The article describes a clinical observation of the ASIT positive effect in persistent atopic dermatitis (AtD) with concomitant respiratory allergy and complete atopic triad development. The authors propose to consider ASIT as a preventive therapy for bronchial asthma and allergic rhinitis if patient has AtD manifestations with confirmed sensitization to aeroallergens.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
